Form D — Crossbow Therapeutics, Inc.
0000905148-25-003444 · filed Sep 30, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $80,000,000
- Reported amount sold
- $30,250,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Crossbow Therapeutics, Inc.
- CIK
- 1972912
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 1030 Massachusetts Ave, Suite 210
Cambridge, Massachusetts 02138 - Phone
- 860-501-1600
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Briggs Morrison · Executive OfficerCambridge, Massachusetts Find on LinkedIn ↗
-
Todd Foley · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Alexandra Cantley · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Irena Melnikova · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Charles Baum · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Sakae Asanuma · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Alon Lazarus · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Dmitri Wiederschain · Executive OfficerCambridge, Massachusetts Find on LinkedIn ↗
-
Alexander Nolte · Executive OfficerCambridge, Massachusetts Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗